U.S. military training missions are an economical way to promote security and good governance and to support our friends and allies and prepare them to tackle these problems on their own, as well as help other countries in the region. 

Adding a new mandatory "comparative effectiveness" test to the approval process for new drugs in the reauthorization of the Food and Drug Administration (FDA) Prescription Drug User Fee Act constitutes a needless waste of time and money.

The FDA's efforts to resolve scientific differences and to take final actions are causing it to miss review goals that it commits to as part of the PDUFA.

Think the contraception decision was bad? Wait until bureaucrats start telling your insurer which cancer screenings to cover.

This is an all too familiar story, the FDA impeding useful innovations in the US entrepreneurs here are forced to test promising medical devices in costly animal studies for years before they can advance their products into clinical trials. In response, American device makers are moving their business overseas.

What impact does the Centers for Medicare & Medicaid Services drug coverage have on the future of biologic products?

The FDA should be required to disclose its reasons for rejecting a drug, and Congress should reaffirm the provisions of the FDA Modernization Act.

The decision of an FDA advisory panel to recommend accelerated approval of the cancer drug Iressa was indeed a revolt of the doctors.